Evidence: US Healthcare, Third Leading Cause of Death_Institute of Medicine, JAMA, 2000
Click here for full article
Similar Posts
Disasterous Drug Trial_FDA New Rules Ensure More Disasters to Follow
Unless Congress acts to overrule the FDA, research disasters such as occurred in London, when six healthy men were exposed to an experimental substance that brought them close to death, are likely to occur with increased frequency.
Zolft pediatric study in JAMA challenged by peers – JAMA letters
Zolft pediatric study in JAMA challenged by peers – JAMA letters Fri, 9 Jan 2004 At the time that two manufacturers publicly acknowledged that their antidepressant drugs (Paxil / Seroxat and Effexor) were unsafe, and ineffective for children, the Journal of the American Medical Association (JAMA) published a clinical trial…
Guinea Pig Gang: Meet U.S. Students Who Rent Their Bodies for Cash
A series of news reports may be a rude awakening to the fact that there are hidden, potentially lethal hazards of participating in clinical trials—and those hazards are concealed from the human guinea pigs who are enticed with promise of easy money.
Serious Adverse Reaction in Gene Therapy- France & US Halt Trials
Serious Adverse Reaction in Gene Therapy- France & US Halt Trials October 4, 2002 Gene therapy treatment that appears to cure a rare immune disorder often referred to as "bubble boy disease” or SCID, caused by a mutation of the x chromosome in boys, were suspended in France and the…
Stanford University Drug Test on Incarcerated Juveniles 1997-1999
Stanford University researchers used 61 inmates ranging in age from 14 to 18 at a California Youth Authority (CYA) correctional center in an experiment testing the psychotropic drug, Depakote.
New Diabetes Drug Increases Mortality / Morbidity – FDA "approvable" letter Challenged
New Diabetes Drug Increases Mortality / Morbidity – FDA “approvable” letter Challenged Fri, 21 Oct 2005 Today’s newspaper reports about a lethal new diabetes drug that the FDA was poised to approve makes abundantly clear that The New York Times got it wrong when it gave the FDA high marks…